Given the important role of l-carnitine in fatty acid transport and metabolism, early studies of BB (sometimes coined prel-carnitine) focused on its ability to form l-carnitine and facilitate fatty acid transport (32, 39)
Sikiric, P., eparovic, J., Anic, T., Buljat, G., Mikus, D., Seiwerth, S., Grabarevic, Z., Stancic-Rokotov, D., Pigac, B., Hanzevacki, M., Marovic, A., Rucman, R., Petek, M., Zoricic, I., Ziger, T., Aralica, G., Konjevoda, P., Prkacin, I., Gjurain, M., Rotkvic, I
His groundbreaking work on preproglucagon (PPG) neurons, and on the bloodbrain barriers role in limiting GLP-1s access to the brain, is redefining how we think about obesity, appetite, and drug development
To address this issue, drug delivery systems for oral peptides have been developed to improve the cellular permeability of peptides using absorption enhancers [e.g., sodium N-[8-(2-hydroxybenzoyl)amino]caprylate (SNAC), bile acids, -cyclodextrin, and cell-penetrating peptides] and ingestible devices [e.g., self-orienting millimeter-scale applicator (SOMA), liquid-injecting SOMA, luminal unfolding microneedle injector, and magnetic-controlled microneedle robots] [22,23,24,25,26,27,28]
Any delays in phase 3 results, safety signals, or manufacturing readiness could push the timeline further back
The findings, published in the journal Diabetes, Obesity and Metabolism, provide real-world context to previous randomized clinical trials indicating that patients who stopped semaglutide (sold under the brand names Ozempic/Wegovy) and tirzepatide (sold under the brand names Mounjaro/Zepbound) regained more than half of the weight they lost within 12 months